Companies / Adaptive Biotechnologies Corp / Activity
Activity — Adaptive Biotechnologies Corp
147 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Bobulsky Susan Executive | Grant | Common Stock | $0 | +63K +15.37% | 469,113 0.29% of shares | low |
| Mar 4, 2026 | Bobulsky Susan Executive | Grant | Common Stock | $0 | +59K +17.10% | 406,613 0.25% of shares | low |
| Mar 4, 2026 | Benzeno Sharon Executive | Grant | Common Stock | $0 | +39K +13.16% | 335,854 0.21% of shares | low |
| Mar 6, 2026 | Robins Harlan S Executive | Grant | Common Stock | $0 | +709K +55.27% | 1,992,324 1.25% of shares | low |
| Mar 4, 2026 | Robins Harlan S Executive | Grant | Common Stock | $0 | +128K +11.06% | 1,283,104 0.80% of shares | low |
| Mar 4, 2026 | Rubinstein Julie Executive | Grant | Common Stock | $0 | +81K +14.12% | 656,485 0.41% of shares | low |
| Mar 4, 2026 | Piskel Kyle Executive | Grant | Common Stock | $0 | +62K +28.56% | 278,512 0.17% of shares | low |
| Mar 4, 2026 | Lo Francis Executive | Grant | Common Stock | $0 | +44K +13.94% | 360,041 0.23% of shares | low |
| Mar 6, 2026 | Robins Chad M CEO | Grant | Common Stock | $0 | +709K +34.39% | 2,771,280 1.74% of shares | low |
| Mar 4, 2026 | Robins Chad M CEO | Grant | Common Stock | $0 | +128K +6.61% | 2,062,060 1.29% of shares | low |
| Mar 4, 2026 | Owen Katey Einterz Director | Grant | Common Stock | $0 | +16K +21.51% | 88,254 0.06% of shares | low |
| Mar 4, 2026 | Hershberg Robert Director | Grant | Common Stock | $0 | +16K +33.44% | 62,347 0.04% of shares | low |
| Mar 4, 2026 | Neupert Peter M Director | Grant | Common Stock | $0 | +16K +6.95% | 240,315 0.15% of shares | low |
| Mar 4, 2026 | Griffin Michelle Renee Director | Grant | Common Stock | $0 | +16K +101.50% | 31,019 0.02% of shares | low |
| Mar 10, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $4.9K | +400 +0.06% | 662,931 0.42% of shares | low |
| Dec 22, 2025 | Lo Francis Executive | Exercise | Common Stock | $8.6K | +1K +0.35% | 317,078 0.20% of shares | low |
| Dec 22, 2025 | Lo Francis Executive | Exercise | Common Stock | $8.8K | +2K +0.69% | 320,372 0.20% of shares | low |
| Dec 22, 2025 | Lo Francis Executive | Exercise | Common Stock | $9.3K | +1K +0.35% | 318,178 0.20% of shares | low |
| Jan 2, 2026 | Lo Francis Executive | Exercise | Common Stock | $12.5K | +3K +0.99% | 319,103 0.20% of shares | low |
| Mar 20, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $25.8K | +4K +0.80% | 494,521 0.31% of shares | low |
| Feb 4, 2026 | Piskel Kyle Executive | Exercise | Common Stock | $26.0K | +2K +0.99% | 218,782 0.14% of shares | low |
| Mar 27, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $34.2K | -3K -0.57% | 480,876 0.30% of shares | low |
| Mar 3, 2026 | Robins Chad M CEO | Sell | Common Stock | $38.4K | -2K -0.12% | 1,934,247 1.21% of shares | low |
| Feb 4, 2026 | Piskel Kyle Executive | Sell | Common Stock | $39.6K | -2K -0.98% | 216,637 0.14% of shares | low |
| Jan 2, 2026 | Lo Francis Executive | Sell | Common Stock | $50.3K | -3K -0.98% | 315,978 0.20% of shares | low |
| Jan 12, 2026 | Piskel Kyle Executive | Exercise | Common Stock | $52.1K | +4K +1.98% | 220,927 0.14% of shares | low |
| Jan 12, 2026 | Lo Francis Executive | Exercise | Common Stock | $56.7K | +14K +3.73% | 395,568 0.25% of shares | low |
| Mar 12, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $72.5K | -5K -1.04% | 512,272 0.32% of shares | low |
| Dec 22, 2025 | Lo Francis Executive | Sell | Common Stock | $76.9K | -4K -1.37% | 315,978 0.20% of shares | low |
| Jan 12, 2026 | Piskel Kyle Executive | Sell | Common Stock | $77.2K | -4K -1.94% | 216,637 0.14% of shares | low |
| Mar 20, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $78.4K | +11K +2.18% | 505,304 0.32% of shares | low |
| Jan 12, 2026 | Lo Francis Executive | Exercise | Common Stock | $93.8K | +8K +2.19% | 360,351 0.23% of shares | low |
| Mar 19, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.97% | 509,642 0.32% of shares | low |
| Mar 18, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.95% | 513,980 0.32% of shares | low |
| Mar 17, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.92% | 518,318 0.32% of shares | low |
| Mar 16, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.90% | 522,656 0.33% of shares | low |
| Mar 13, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.87% | 526,994 0.33% of shares | low |
| Mar 12, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.85% | 531,332 0.33% of shares | low |
| Mar 11, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.83% | 535,670 0.34% of shares | low |
| Mar 10, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.27% | 662,531 0.42% of shares | low |
| Mar 9, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.26% | 666,869 0.42% of shares | low |
| Mar 6, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.24% | 671,207 0.42% of shares | low |
| Mar 5, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.54% | 594,295 0.37% of shares | low |
| Mar 4, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.52% | 598,633 0.38% of shares | low |
| Mar 3, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $96.4K | +15K +2.50% | 602,971 0.38% of shares | low |
| Mar 3, 2026 | Rubinstein Julie Executive | Sell | Common Stock | $106.4K | -7K -1.10% | 583,911 0.37% of shares | medium |
| Mar 31, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $107.0K | +15K +3.20% | 474,938 0.30% of shares | low |
| Mar 30, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $107.0K | +15K +3.17% | 479,276 0.30% of shares | low |
| Mar 27, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $107.0K | +15K +3.14% | 483,614 0.30% of shares | low |
| Mar 26, 2026 | Rubinstein Julie Executive | Exercise | Common Stock | $107.0K | +15K +3.11% | 487,952 0.31% of shares | low |